TZ5-19138-10091
4 vaccinations
2 coded responses
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 086 / NJ
- Registered
- 2022-09-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Dose 1 — Pfizer-BioNTech
-
2021-04-03
Dose 2 — Pfizer-BioNTech
-
2021-11-13
Dose 3 — Pfizer-BioNTech
-
2022-09-27
Registered in v-safe
-
2022-09-27
Dose 4 — Moderna
- 2022-09-27
-
2022-09-28
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body achesAdult check-in
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-09-30
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodeMedDRA releases: 2024-11 · check-in free text available
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-03
- 2022-11-08
- 2022-12-27
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | No |
| 2 | 2021-04-03 | Pfizer-BioNTech | No |
| 3 | 2021-11-13 | Pfizer-BioNTech | No |
| 4 | 2022-09-27 | Moderna | No |
Free text
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Swollen lymph node
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release